Research Projects & Grants

For Profit Organization

• A Prospective, Multicountry Study to Estimate the Incidence of and Provide a Best Practice Model for Monitoring the Development of Post-Stroke Spasticity, Role: Investigator, Ipsen Pharma SAS, (04/2025) Status: Approved
• An Open-Label Study to Evaluate the Phannacokinetics, Phannacodynamics, Efficacy, and Safety of a Single Dose of ANX005 in Participants With Guillain-Barre Syndrome. Protocol: ANX00S-GBS-05, Role: Investigator, Annexon, Inc., (04/2026 - 04/2027) Status: Approved
• GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study, Role: Investigator, W.L. Gore & Associates, Inc., (05/2026 - 05/2027) Status: Approved
• Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JXlO in Acute lschemic Stroke with Late Presentations. Protocol: Jx:10002, Role: Investigator, Corxel Pharmaceuticals, (02/2026 - 02/2027) Status: Approved